AI

Jan 2025

Why EDC Needs RBQM for Smarter Clinical Trial Management

By |2025-01-15T10:04:42+02:00January 14, 2025|Blog, News|Comments Off on Why EDC Needs RBQM for Smarter Clinical Trial Management

With ICH E6(R3) reinforcing proactive quality management, relying on EDC systems with hundreds of edit checks is impractical. The MyRBQM Portal bridges the gap with predictive analytics, historical data views, and real-time risk drill-downs, enhancing oversight and reducing complexity. Learn how EDC and RBQM work together for more insightful, compliant trial management.

Dec 2024

Streamlining Clinical Trials: FDA Guidance Meets RBQM Strategy

By |2025-01-17T12:35:24+02:00December 31, 2024|Good Clinical Practice, News|Comments Off on Streamlining Clinical Trials: FDA Guidance Meets RBQM Strategy

The recently launched FDA’s draft guidance on protocol deviations highlights the importance of compliance and risk management. Combined with RBQM principles, sponsors can streamline trials, enhance safety, and align with regulations.

Dec 2024

ACDM Features RBQM Shift from ClinOps to Data Science

By |2024-12-31T10:31:39+02:00December 30, 2024|News|Comments Off on ACDM Features RBQM Shift from ClinOps to Data Science

Speaking at the 2nd Annual ACDM Symposium on RBQM, our CEO highlighted how RBQM has evolved from supporting Clinical Operations to becoming an integrated approach to data management.

Sep 2024

EMA Releases New Guidelines for Safe Use of Large Language Models in Regulatory Science

By |2024-09-19T14:22:20+02:00September 19, 2024|AI in Clinical Trials, Good Clinical Practice, News|Comments Off on EMA Releases New Guidelines for Safe Use of Large Language Models in Regulatory Science

The EMA has released key guidelines on the responsible use of large language models (LLMs) in regulatory science. Discover how AI tools like GPT can streamline tasks while addressing privacy and accuracy challenges, and learn about the EMA’s approach to safe and ethical implementation.

Mar 2024

Key Takeaways from PHUSE US Connect 2024

By |2024-05-10T17:03:25+02:00March 5, 2024|AI in Clinical Trials, Blog, News|Comments Off on Key Takeaways from PHUSE US Connect 2024

Explore key takeaways from the PHUSE US Connect 2024 conference, highlighting the future of clinical trials, the importance of data integrity, and the role of AI/ML methodologies. Discover how Cyntegrity's vision for QbD and integrated RBQM is shaping the industry.

Nov 2023

Cyntegrity Hosts Virtual Dialogue on Responsible AI in Clinical Trials

By |2024-05-10T17:00:40+02:00November 2, 2023|AI in Clinical Trials, News|Comments Off on Cyntegrity Hosts Virtual Dialogue on Responsible AI in Clinical Trials

We proudly present our virtual dialogue on Responsible AI in Clinical Trials this November 15 & 16, uniting industry and academic experts for groundbreaking discussions and insights.

Jun 2023

Empowering Clinical Trials: MyRBQM Portal Debuts on Microsoft Azure Marketplace

By |2023-06-27T10:53:08+02:00June 27, 2023|News|0 Comments

MyRBQM Portal has made its debut on the Azure Marketplace. This milestone allows biopharmaceutical companies to streamline and unify their approach to risk management by using the secure and reliable Azure cloud platform.

Nov 2022

Cyntegrity at Metropolitan School Frankfurt

By |2022-11-17T13:43:56+02:00November 9, 2022|Blog, Butterfly Challenge, News|Comments Off on Cyntegrity at Metropolitan School Frankfurt

On the wings of the Butterfly Challenge, our CEO Artem Andrianov and Junior Data Scientist Ting-Yu Ho shared their scientific knowledge with 10th graders helping them acquire real-world vision.

Go to Top